Research Article
SAPHIRE: Stress and Pulmonary Hypertension in Rheumatoid Evaluation—A Prevalence Study
Table 2
Patient characteristics by PAH status (
).
| | | PAH determined by RHC () | PAH determined by EchoCG () | | | No PAH ( [67%]) | PAH ( [33%]) | value | No PAH ( [76%]) | PAH ( [24%]) | value |
| | Age (yrs) | 62.3 ± 9.3 | 58.0 ± 12.7 | 0.66 | 60.0 ± 9.8 | 60.6 ± 11.3 | 0.82 | | WHO Class II | 4 | 2 | — | 56 | 15 | — | | WHO Class III | 0 | 0 | — | 0 | 3 | — | | BMI (kg⋅m−2) | 32.5 ± 5.2 | 35.7 ± 7.3 | 0.06 | 29.0 ± 5.6 | 31.1 ± 5.7 | 0.16 | | CRP (mg⋅L−1) | 20.2 ± 20.0 | 4.1 ± 0 | — | 32.7 ± 57.3 | 23.5 ± 21.0 | 0.55 | | CCP (U⋅L−1) | 223 ± 158.1 | 312 ± 0 | — | 111.8 ± 123.4 | 110.8 ± 115.9 | 0.98 | | PASPr (resting) (mmHg) | 31.8 ± 4.5 | 37.5 ± 14.8 | 0.47 | 25.5 ± 3.3 | 40.8 ± 20.4 | <0.05 | | PASPe (exercise) (mmHg) | 48.8 ± 15.7 | 51.5 ± 9.2 | 0.84 | 28.2 ± 5.0 | 42.5 ± 5.8 | <0.05 | | REEP (rise with exercise) | 17 ± 12.2 | 14 ± 5.7 | 0.77 | 3.1 ± 4.5 | 6.3 ± 21.3 | 0.31 | | DLCO (% predicted) | 80.8 ± 14.2 | 92 ± 14.1 | 0.41 | 85.3 ± 13.3 | 78.8 ± 14.2 | 0.04 | | 6MWD (m) | 382.8 ± 19.2 | 290 ± 12.7 | 0.18 | 441.3 ± 105.8 | 356.8 ± 92.7 | <0.05 |
|
|
